ANTIDEPRESSANT REBOXETINE NO BETTER THAN A PLACEBO, STUDY FINDS
Scientists accuse Pfizer of holding back studies which reveal drug sold as Edronax to be ineffective and potentially harmful. Pfizer has been accused by scientists of failing to disclose studies which show the inadequacies of reboxetine.An antidepressant prescribed in Read More …
